Accelerating Discovery in the Age of a Pandemic

Rapidly developing diagnostic tests, vaccines, and antivirals, and streamlining their production and delivery is critical to combating a pandemic. Scientists in the field of synthetic biology reengineer biological organisms and use their components to accomplish new tasks in medicine, manufacturing, agriculture, and more. With the emergence of SARS-CoV-2, synthetic biologists harnessed the diverse tools of their trade to mitigate the COVID-19 pandemic.

In this virtual symposium brought to you by The Scientist, an expert panel will present how synthetic biology accelerates the development of diagnostics, therapeutics, and the medicinal pipeline.

Symposium program

1:10 PM – A brief message from Beckman Coulter Life Sciences
John Fuller, PhD

1:20 PM – ACE2 receptor traps potently neutralize SARS-CoV-2
Anum Glasgow, PhD

1:50 PM – De novo design of SARS-CoV-2 antivirals, diagnostics, and vaccines
David Baker, PhD

2:20 PM – Designing diagnostics and therapeutics
Pamela Silver, PhD

2:50 PM – Harnessing synthetic biology and deep learning to fight COVID-19
James J. Collins, PhD

3:20 PM – Open panel Q&A session

Annum Glasgow, David Baker, Pamela Silver, and James Collins will be joined by Jeff Glasgow in an open question and answer session where they will address questions posed by the audience.